1. Preclinical Ischemia Model Systems --;1. Primary Cultures for Testing Neuroprotective Drugs --;2. Modeling Neurodegeneration and Neuroprotection in Hippocampal Slices --;3. Stroke Models for Preclinical Trials of Neuroprotective Agents --;4. Animal Models of Ischemia --;5. Head Trauma Model Systems --;2. Neuroprotective Approaches in Stroke and Head Trauma --;6. Excitotoxicity, Cerebral Ischemia, and Neuroprotection by Competitive NMDA Receptor Antagonists --;7. Excitatory Amino Acids and Neuroprotection --;8. Calcium Channel Blockers and Neuroprotection --;9. Self-Defense of the Brain: Adenosinergic Strategies in Neurodegeneration --;10. Gangliosides: New Generation of Neuroprotective Agents --;11. Lazaroids: Novel Cerebroprotective Antioxidants --;12. Membrane-Derived Lipid Second Messengers as Targets for Neuroprotection: Platelet-Activating Factor --;13. Protection Against Oxidative Damage to CNS by?-Phenyl-tert-butyl Nitrone and Other Spin-Trapping Agents: A Novel Series of Nonlipid Free Radical Scavengers --;14. Insulin, Hypoglycemia, and Ischemic Neuroprotection --;15. Temperature Modulation of Neuronal Injury --;3. Clinical Endpoints for Neuroprotective Drugs --;16. Clinical Trial Issues in Stroke Therapy --;17. Excitotoxicity and Neurodegenerative Disorders.
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
In the 1980s the revolutions of molecular biology have been applied aggressively to the neurosciences with molecular cloning for neuropeptide precursors, many important neurochemical en- zymes, and receptors for numerous transmitters.
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Brain -- Degeneration -- Chemotherapy.
موضوع مستند نشده
Brain damage -- Chemotherapy.
موضوع مستند نشده
Cerebral ischemia -- Chemotherapy.
رده بندی کنگره
شماره رده
RC388
.
5
نشانه اثر
P385
1992
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )